{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:09Z","timestamp":1793642349827,"version":"4.5.1"},"reference-count":43,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    Antidepressants are commonly prescribed for children and adolescents, but their discontinuation may result in withdrawal symptoms, though rarely described for this age group in the literature. Systematically examining the types and prevalence of withdrawal syndromes in children and adolescents in accordance with PRISMA guidelines is the aim of the present paper. A search of PubMed, Embase, Web of Science, and Cochrane Library was conducted from inception to December 2024. Inclusion criteria were: clinical populations; subjects aged 2\u201318; antidepressant discontinuation; assessment of withdrawal symptoms; randomized controlled trials (RCTs) or observational studies; rate\/type of withdrawal symptoms. A total of 6227 citations were screened, leading to 12 studies, encompassing 690 participants aged 2\u201318\u2009years, with eight RCTs and four observational studies. The analysis revealed common withdrawal symptoms across various antidepressant classes, predominantly affecting the central nervous and gastrointestinal systems. Symptoms such as nausea (14.6%\u201322.0%), headache (14.6%\u201315.0%), diarrhea (10.0%\u201322.0%), depression (10%), inner tension (44%), anxiety\/worry (44%), and cough (33%) were frequently observed, especially after discontinuation of selective serotonin reuptake inhibitors. Such symptoms clustered in new withdrawal symptoms according to a diagnostic classification of withdrawal syndromes at discontinuation of antidepressants used in adults. Withdrawal symptoms and withdrawal syndromes following antidepressant discontinuation in children and adolescents are still neglected but pose significant clinical challenges, often resembling or exacerbating underlying conditions. Future research is needed, as well as a systematic assessment of these symptoms in the clinical realm (registered in OSF DOI:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/GYQ9Z\">https:\/\/doi.org\/10.17605\/OSF.IO\/GYQ9Z<\/jats:ext-link>\n                    ).\n                  <\/jats:p>","DOI":"10.1177\/20451253251404780","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:13:48Z","timestamp":1766391228000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute and persistent withdrawal syndromes following discontinuation of antidepressants in children and adolescents: a systematic review"],"prefix":"10.1177","volume":"15","author":[{"given":"Jianjun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology and Psychology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China"},{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-0488","authenticated-orcid":false,"given":"Fiammetta","family":"Cosci","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, Via di San Salvi, 12, Florence 50135, ItalyDepartment of Psychiatry &amp; Neuropsychology, Maastricht University, Maastricht, The Netherlands International Lab of Clinical Measurements, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003215"},{"issue":"5","key":"e_1_3_4_3_2","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick SE","year":"2021","unstructured":"Hetrick SE, McKenzie JE, Bailey AP, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev 2021; 5(5): CD013674.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2432"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000540031"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000522241"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000516031"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000506868"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000491524"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000530692"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.08.027"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000370338"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320980573"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19com12794"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2224557"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/21677026221125180"},{"issue":"4","key":"e_1_3_4_17_2","article-title":"Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults","volume":"4","author":"Van Leeuwen E","year":"2021","unstructured":"Van Leeuwen E, van Driel ML, Horowitz MA, et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev 2021; 4(4): CD013495.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"3","key":"e_1_3_4_20_2","article-title":"Standard 6: age groups for pediatric trials","volume":"129","author":"Williams K","year":"2012","unstructured":"Williams K, Thomson D, Seto I, et al. Standard 6: age groups for pediatric trials. Pediatrics 2012; 129(3): S153\u2013S160.","journal-title":"Pediatrics"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-20-00364"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000371865"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.10.041"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-015-0025-9"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.0001"},{"key":"e_1_3_4_26_2","first-page":"11","article-title":"A pilot study of citalopram treatment in preventing relapse of depressive episode after acute treatment","volume":"25","author":"Cheung A","year":"2016","unstructured":"Cheung A, Levitt A, Cheng M, et al. A pilot study of citalopram treatment in preventing relapse of depressive episode after acute treatment. J Can Academy Child Adolesc Psychiatry 2016; 25: 11\u201316.","journal-title":"J Can Academy Child Adolesc Psychiatry"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2023.0048"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07091453"},{"issue":"1","key":"e_1_3_4_29_2","article-title":"Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?","volume":"13","author":"Geller DA","year":"2003","unstructured":"Geller DA, Biederman J, Stewart SE, et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 2003; 13(1): S19\u2013S29.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/10445460050167304"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198708000-00008"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.5.647"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.59"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.1362"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18121419"},{"key":"e_1_3_4_36_2","first-page":"817","volume-title":"Pharmacoepidemiology and therapeutic risk management","author":"Hartzema AG","year":"2008","unstructured":"Hartzema AG, Tilson HH, Chan KA. Pharmacoepidemiology and therapeutic risk management. Harvey Whitney Books Company, Harvey Whitney Books, 2008, pp. 817\u2013854."},{"issue":"1","key":"e_1_3_4_37_2","first-page":"4","article-title":"Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice","volume":"25","author":"Garland EJ","year":"2016","unstructured":"Garland EJ, Kutcher S, Virani A, et al. Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice. J Can Acad Child Adolesc Psychiatry 2016; 25(1): 4\u201310.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"4","key":"e_1_3_4_38_2","first-page":"489","article-title":"Facing the evidence: antidepressant treatment in children and adolescents","volume":"170","author":"Garland EJJC","year":"2004","unstructured":"Garland EJJC. Facing the evidence: antidepressant treatment in children and adolescents. CMAJ 2004; 170(4): 489\u2013491.","journal-title":"CMAJ"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2767"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2022.04.014"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab252"},{"key":"e_1_3_4_42_2","first-page":"95","article-title":"The diagnostic clinical interview for drug withdrawal 1 (DID-W1) \u2013 new symptoms of selective serotonin reuptake inhibitors (SSRI) or serotonin norepinephrine reuptake inhibitors (SNRI): inter-rater reliability","volume":"53","author":"Cosci F","year":"2018","unstructured":"Cosci F, Chouinard G, Chouinard VA, et al. The diagnostic clinical interview for drug withdrawal 1 (DID-W1) \u2013 new symptoms of selective serotonin reuptake inhibitors (SSRI) or serotonin norepinephrine reuptake inhibitors (SNRI): inter-rater reliability. Riv Psichiatr 2018; 53: 95\u201399.","journal-title":"Riv Psichiatr"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001491"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00126-7"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253251404780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253251404780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253251404780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:53:53Z","timestamp":1777593233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253251404780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"alternative-id":["10.1177\/20451253251404780"],"URL":"https:\/\/doi.org\/10.1177\/20451253251404780","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"article-number":"20451253251404780"}}